This study is for patients with high risk prostate cancer. PSA must be >20 ng/ml. Patient must have a Gleason score of 8-10. Patient cannot have metastatic disease outside of pelvic lymph nodes. No prior radiation or androgen deprivation therapy allowed.
Contact phone
Tracy Bellefeuil | (517) 364-2835
Contact email
[email protected]
Principal investigator
Dr. Srkalovic, MD, PhD
Trial Category
Cancer
Trial SubCategory
Prostate
Webform